{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:29:06Z","timestamp":1773379746982,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025092","name":"Ministry of Health, Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","award":["-035"],"award-info":[{"award-number":["-035"]}],"id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013885","name":"Kementerian Kesihatan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025090","name":"Ministry of Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ctro.2024.100873","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:00:09Z","timestamp":1728597609000},"page":"100873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario"],"prefix":"10.1016","volume":"50","author":[{"given":"Stephane","family":"Thibodeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Ynoe de","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Pantarotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2024.100873_b0005","unstructured":"Robinson A, Vella ET, Ellis PM, Goffin R, Hanna W, Maziak D, et al. Recommendations for treatment of patients with clinical stage III non-small cell lung cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance. Toronto (ON): Ontario Health (Cancer Care Ontario); 2020 April 27. Program in Evidence-Based Care Guideline No.: 7-3 Version 4."},{"issue":"1","key":"10.1016\/j.ctro.2024.100873_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)","volume":"6","author":"Brahmer","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2024.100873_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.12.039","article-title":"Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis","volume":"95","author":"McGrath","year":"2010","journal-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.ctro.2024.100873_b0020","doi-asserted-by":"crossref","unstructured":"Imano N, Kimura T, Kawahara D, Kubo K, Takeuchi Y, Saito A, et al. Potential Benefits of Volumetric Modulated Arc Therapy to Reduce the Incidence of Grade 2 Radiation Pneumonitis in Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients, International Journal of Radiation Oncology Biology Physics, Volume 111, Issue 3, Supplement, 2021, Page e439, ISSN 0360-3016, https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.1244.","DOI":"10.1016\/j.ijrobp.2021.07.1244"},{"key":"10.1016\/j.ctro.2024.100873_b0025","first-page":"e851","article-title":"Factors associated with the use of radiation therapy in patients with stage III non-small cell lung cancer in Alberta, Canada: a population-based study","volume":"8","author":"Liu","year":"2016","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ctro.2024.100873_b0030","doi-asserted-by":"crossref","first-page":"e0230444","DOI":"10.1371\/journal.pone.0230444","article-title":"Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer","volume":"15","author":"Bobbili","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ctro.2024.100873_b0035","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/j.cllc.2018.05.009","article-title":"Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis","volume":"19","author":"Berry","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctro.2024.100873_b0040","unstructured":"The Constitution Acts, 30 & 31 Victoria, C-3 (UK) (1867). https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-6\/page-1.html."},{"key":"10.1016\/j.ctro.2024.100873_b0045","unstructured":"Government of Ontario (2023, April 22). About Ontario. https:\/\/www.destinationontario.com\/en-ca\/travel-resources\/about-ontario."},{"key":"10.1016\/j.ctro.2024.100873_b0050","unstructured":"Canada Health Act, R.C.S., C-6 (1985). https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-6\/page-1.html."},{"issue":"5","key":"10.1016\/j.ctro.2024.100873_b0055","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/curroncol28050286","article-title":"Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study","volume":"28","author":"Goldie","year":"2021","journal-title":"Current Oncology (Toronto, Ont)"},{"key":"10.1016\/j.ctro.2024.100873_b0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13014-018-1142-7","article-title":"Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database","volume":"13","author":"Miller","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100873_b0065","first-page":"2","article-title":"Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study","volume":"46","author":"de Rijke","year":"2005","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.ctro.2024.100873_b0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1634\/theoncologist.2009-0198","article-title":"How Does Older Age Influence Oncologists\u2019 Cancer Management?","volume":"15","author":"Foster","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ctro.2024.100873_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12094-012-0782-6","article-title":"Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians","volume":"14","author":"Giron\u00e9s","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2024.100873_b0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lungcan.2010.05.001","article-title":"Patients\u2019 preferences for chemotherapy in non-small cell lung cancer: A systematic review","volume":"69","author":"Blinman","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2024.100873_b0085","first-page":"3","article-title":"Older people with cancer: perceptions and feelings about information, decision-making and treatment\u2014a pilot study","volume":"8","author":"Chouilara","year":"2004","journal-title":"Eur J Onc Nurs"},{"issue":"3","key":"10.1016\/j.ctro.2024.100873_b0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/cer-2020-0173","article-title":"Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer","volume":"10","author":"Kim","year":"2021","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.ctro.2024.100873_b0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.lungcan.2020.10.001","article-title":"Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis","volume":"150","author":"Limonnik","year":"2020","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"9","key":"10.1016\/j.ctro.2024.100873_b0100","first-page":"33","article-title":"Measuring \u201crurality\u201d for purposes of health-care planning: an empirical measure for Ontario","volume":"67","author":"Kralj","year":"2000","journal-title":"Ont Med Rev"},{"key":"10.1016\/j.ctro.2024.100873_b0105","doi-asserted-by":"crossref","unstructured":"Mackillop WJ, Hanna TP, Brundage MD. Chapter 12 - Health Services Research in Radiation Oncology: Toward Achieving the Achievable for Patients with Cancer, Editor(s): Leonard L. Gunderson, Joel E. Tepper, Clinical Radiation Oncology (Fourth Edition), Elsevier, 2016, Pages 217-238.e2, ISBN 9780323240987. https:\/\/doi.org\/10.1016\/B978-0-323-24098-7.00012-5.","DOI":"10.1016\/B978-0-323-24098-7.00012-5"},{"key":"10.1016\/j.ctro.2024.100873_b0110","series-title":"Real-Time Routing with OpenStreetMap Data","first-page":"513","author":"Luxen","year":"2011"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:30:50Z","timestamp":1733959850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":22,"alternative-id":["S2405630824001502"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100873","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100873"}}